HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tor Ny Selected Research

Plasminogen

12/2020The plasminogen receptor, Plg-RKT, plays a role in inflammation and fibrinolysis during cutaneous wound healing in mice.
1/2020Plasminogen is a master regulator and a potential drug candidate for the healing of radiation wounds.
10/2018Plasminogen activation is required for the development of radiation-induced dermatitis.
1/2016Plasminogen is a critical regulator of cutaneous wound healing.
1/2015A reply to the commentary on "Animal models of chronic tympanic membrane perforation: in response to plasminogen initiates and potentiates the healing of acute and chronic tympanic membrane perforations in mice" by Wang AY, Shen Y, Wang JT, Eikelboom RH and Dilley RJ; Clin Translat Med, 2014; 3:5.
6/2012Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds.
8/2011Plasmin is essential in preventing periodontitis in mice.
1/2011Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.
3/2008Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis.
1/2008Lack of plasminogen does not alter the early inflammatory response following a tympanic membrane perforation: a study in plasminogen-deficient mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tor Ny Research Topics

Disease

8Inflammation (Inflammations)
12/2020 - 03/2005
7Wounds and Injuries (Trauma)
12/2020 - 08/2005
4Arthritis (Polyarthritis)
03/2008 - 03/2005
2Neoplasms (Cancer)
01/2020 - 10/2018
2Infections
12/2018 - 01/2011
2Tympanic Membrane Perforation
01/2015 - 01/2008
2Rupture
07/2006 - 04/2004
2Rheumatoid Arthritis
08/2005 - 03/2005
1Burns
12/2020
1Fibrosis (Cirrhosis)
01/2020
1Glomerulonephritis
12/2018
1Myocarditis (Carditis)
12/2018
1Yersinia Infections
12/2018
1Reactive Arthritis (Reiter Disease)
12/2018
1Persistent Infection
12/2018
1Radiodermatitis
10/2018
1Ulcer
10/2018
1Staphylococcal Infections
10/2014
1Periodontitis
08/2011
1Periodontal Diseases (Periodontal Disease)
08/2011
1Chronic Periodontitis
08/2011
1Sepsis (Septicemia)
01/2011
1Infectious Arthritis (Septic Arthritis)
03/2008
1Edema (Dropsy)
01/2008
1Otitis Media
11/2006
1Necrosis
08/2005
1Experimental Arthritis
08/2005
1Osteoarthritis
11/2004
1Ankylosis
11/2004

Drug/Important Bio-Agent (IBA)

14PlasminogenIBA
12/2020 - 03/2005
8FibrinolysinFDA Link
10/2018 - 03/2005
4CytokinesIBA
12/2020 - 03/2008
4Plasminogen Activators (Plasminogen Activator)IBA
10/2018 - 03/2005
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2011 - 03/2005
2FibrinIBA
12/2020 - 01/2016
2AntigensIBA
12/2018 - 08/2005
2Proteins (Proteins, Gene)FDA Link
01/2016 - 10/2014
2Nerve Growth Factor (NGF)IBA
10/2014 - 01/2008
2estropipate (Ogen)FDA LinkGeneric
01/2011 - 03/2008
1Caspase 14IBA
12/2020
1Fibrinogen (Factor I)FDA Link
12/2020
1Filaggrin ProteinsIBA
12/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Arachidonic Acid (Vitamin F)IBA
01/2020
1Bacterial Proteins (Bacterial Protein)IBA
12/2018
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1Surface Antigens (Surface Antigen)IBA
12/2018
1Tranexamic Acid (AMCA)FDA Link
10/2018
1CollagenIBA
01/2016
1VimentinIBA
01/2016
1Cystine (L-Cystine)IBA
10/2014
1Biological ProductsIBA
06/2012
1Peptide Hydrolases (Proteases)FDA Link
08/2011
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2011
1Interleukin-6 (Interleukin 6)IBA
03/2008
1Interleukin-10 (Interleukin 10)IBA
03/2008
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2008
1Nerve Growth Factors (Neurotrophins)IBA
01/2008
14-O-carboxymethylascochlorinIBA
01/2008
1Matrix Metalloproteinases (MMPs)IBA
07/2006
1Collagen Type II (Type II Collagen)IBA
03/2005
1Monoclonal AntibodiesIBA
03/2005
1Alkaline PhosphataseIBA
11/2004
1Plasminogen Activator Inhibitor 1IBA
04/2004

Therapy/Procedure

2Radiotherapy
01/2020 - 10/2018
2Therapeutics
08/2011 - 11/2006
2Injections
08/2005 - 03/2005
1Debridement
01/2016
1Intravenous Injections
01/2011